醫(yī)學會議中心

　　會議時間：2015-05-20至2015-05-21

　　會議地點：上海市

　　聯(lián) 系 人：marketing@wbfgroup.com 86-21-31602153（固話）

　　會議介紹：

　　專家預測全球疫苗市場規(guī)模在2015年時，預計會擴大規(guī)模到350億美金。依照Global行業(yè)Analysts（GIA）的分析，全球的疫苗業(yè)界，從2009年到2014年為止在年平均9.7%的基準中成長，預計從2009年到2017年為止以15%驚人的步伐成長。由于在研發(fā)策略，合作模式創(chuàng)新，技術轉(zhuǎn)移、大規(guī)模生產(chǎn)、多產(chǎn)品生產(chǎn)的新廠房建設、新產(chǎn)品及先進生物技術許可引進等方面大量市場需求，全球疫苗產(chǎn)業(yè)增長絕大多數(shù)來自于亞洲新興市場，特別是中國和印度兩國。此外在中國國內(nèi)，進行大規(guī)模的醫(yī)療改革，國家食品藥物監(jiān)督管理總局（SFDA）也取得WHO的認定，相信中國在今后國際疫苗市場上會扮演很重要的角色。

　　做為我們非常成功的生物制藥和疫苗峰會系列的一部分，本次峰會將吸引超過180位疫苗領域的企業(yè)高層管理者參與，80%的參會者為總監(jiān)級別以上職位。絕大多數(shù)參會者來自跨國或本土的制藥企業(yè)、疫苗生產(chǎn)商，生物技術公司及研發(fā)與生產(chǎn)技術設備企業(yè)，相關政府官員、大學教授及科研院所每年也競相參與本會議。尋求新的商業(yè)合作機會并與行業(yè)同行們交流學習如何解決當前行業(yè)熱點問題及挑戰(zhàn)，如探討在亞洲特別是在中國的最新疫苗產(chǎn)業(yè)趨勢，政策、法規(guī)、WHO預認證等一系列話題，研發(fā)合作戰(zhàn)略，創(chuàng)新的生產(chǎn)技術，打造世界級的中國疫苗產(chǎn)業(yè)體系。我們的宗旨是通過對熱點話題的深入探討、交流和學習，促進疫苗企業(yè)在研發(fā)、生產(chǎn)、注冊及市場準入等方面的區(qū)域性國際合作�？梢岳�用此次峰會，加強與中國和全球各國疫苗業(yè)界相關企業(yè)、創(chuàng)新解決方案的供應商、監(jiān)督機構(gòu)等與會嘉賓進行意見交換，以及發(fā)展策略性合作關系的寶貴機會。

　　如果您期望與亞洲疫苗開發(fā)與生產(chǎn)領域的決策者們會面及交流學習，這里將是您唯一正確的選擇。令您及您的團隊始終處于亞洲疫苗發(fā)展最前沿，盡在2015年5月20-21日的Asia疫苗發(fā)展領袖年會，期待您的參與！

　　屆時峰會將有國際主題演講，產(chǎn)業(yè)及學術報告，眾多交流機會，將為高端科技及商業(yè)探討打造一個互動的平臺。我們歡迎閣下致電我們86-21-31602153獲取更多信息，或把您的問題發(fā)送至我們電郵marketing@wbfgroup.com .

　　Asia Vaccine Development Leaders Summit 2015

　　About AVDLS 2015

　　The outlook of the vaccine industry is one of continued growth and is predicted to reach $35billion by 2015. the Asia vaccine industry is expected to grow at an astonishing rate of 15% from 2009-2017 according to GIA. Vaccine industry in Asian emerging markets such as China and India is contributing the majority of growth for the market thanks to the huge demand for Research and development strategy， Novel partnership model，technology transfer， scaling up， manufacturing technology advancement ，new facilities for multi-products， and also licensing rights for the access to novel vaccines and advanced biotech in Asia.

　　China， being the world‘s largest vaccine producer， is prepared to take on a larger role in the international vaccine market after the recent healthcare reform and the acknowledgement of SFDA （State Food and Drug Administration） by WHO.

　　A part of our highly successful Clinical Trials series， the event， which attracts over 180 attendees from Global vaccine manufacturers，academic researchers， veterinarians， vaccine policy makers，novel development and manufacturing techonolgy and equipment provider will build upon AVDLS 2015 held in May 20th and 21th in Parkyard Hotel Shanghai ，China and examine latest industrial trends， R&D strategies， partnership models ， vaccine development and manufacturing technology advancements in Asia， you will hear the challenges and triumphs of product developers who continue to advance their innovations to combat emerging and infectious diseases. This event promises to provide participants an avenue to meet Asia vaccine industry players， innovative solutions providers and regulatory officials from around the world to discuss， innovate and forge strategic partnerships.

　　With over 30 speakers and estimation to bring over 180 Vaccine professionals， the key congress topics will cover：

　　Asian Regulation ， Industrial Trends， R&D Strategies

　　Novel Vaccines Development： Innovations & Applications

　　Improving Vaccine Therapeutic Efficacy

　　Exploring vaccine R&D Technologies & Manufacturing

　　Cell Culture Technology for Vaccine Manufacturing

　　Designing the Next Generation of Vaccine Adjuvants

　　New building of a multipurpose vaccine production facility

　　Next Generation Vaccines Development and Biotech for Asia

　　Changing State of Veterinary Vaccine R&D in Asia

　　Best practices for GMP，QA/QC，& WHO PQ Review

　　On behalf of the committee，we sincerely hope primary discussions，topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches，panel/roundtable discussions，open Q&A sessions，booth and poster exhibition and guided networking sessions for all professionals and management who are working for the Vaccine development and production in Asia.